ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 144 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q2 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $519,000 | -7.2% | 396,362 | +24.7% | 0.01% | +16.7% |
Q4 2021 | $559,000 | -46.6% | 317,800 | -34.2% | 0.01% | -57.1% |
Q3 2021 | $1,047,000 | +705.4% | 482,663 | +1202.2% | 0.01% | +1300.0% |
Q2 2021 | $130,000 | -0.8% | 37,064 | +206.0% | 0.00% | 0.0% |
Q4 2020 | $131,000 | -39.6% | 12,112 | +16.6% | 0.00% | -83.3% |
Q2 2020 | $217,000 | – | 10,384 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sonic Fund II, L.P. | 4,109,867 | $42,332,000 | 29.76% |
Versant Venture Management, LLC | 7,003,892 | $72,140,000 | 13.20% |
Ghost Tree Capital, LLC | 1,161,375 | $11,962,000 | 3.46% |
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 480,000 | $4,944,000 | 2.54% |
Soleus Capital Management, L.P. | 364,349 | $3,753,000 | 1.99% |
RTW INVESTMENTS, LP | 7,234,764 | $74,518,000 | 1.79% |
RA Capital Management | 9,410,860 | $96,932,000 | 1.77% |
FRAZIER MANAGEMENT LLC | 1,437,028 | $14,801,000 | 1.33% |
Casdin Capital, LLC | 2,750,000 | $28,325,000 | 1.27% |
Avoro Capital Advisors LLC | 8,000,000 | $82,400,000 | 1.17% |